These data suggest that PDLIM2 repression, especially in lung myeloid cells, is a common mechanism driving COPD, ILD/IPF, and lung cancer and increasing patients’ susceptibility to infection. The gene discussed is PDLIM2; the disease is idiopathic pulmonary fibrosis.